Childhood-onset systemic lupus erythematosus (cSLE) is a chronic, severe autoimmune disorder that carries a risk of early organ damage.
APONTIS PHARMA and Zentiva enter into investment agreement – Zentiva will launch a voluntary public purchase offer – Biotech Investments
APONTIS PHARMA AG / Key word(s): Tender Offer APONTIS PHARMA and Zentiva enter into investment agreement – Zentiva will launch a voluntary public purchase offer